Special Issue "Adipokines 3.0"
Deadline for manuscript submissions: 28 February 2021.
Interests: adipose tissue; obesity; non-alcoholic fatty liver disease; adiponectin; chemerin
Special Issues and Collections in MDPI journals
Special Issue in International Journal of Molecular Sciences: Adipokines 2.0
Special Issue in Cancers: Chemerin Signaling in Cancer
This Special Issue, “Adipokines 3.0”, will cover a selection of original research articles and current review articles related to the role of adipokines in health and disease. Up-to-date review articles, commentaries, and experimental papers are all welcome.
Adipokines act in an autocrine, paracrine, or endocrine manner. Although adipokine levels have emerged as promising biomarkers in various diseases, they are not used as predictive or diagnostic markers in clinical practice yet. The leptin analog “recombinant methionyl human leptin”, though, has been approved for the treatment of patients with generalized and partial lipodystrophy already.
Over the past decade, associations among adipokines and obesity, cardiovascular disease, type 2 diabetes, cancer, fertility, and many more have been identified. Further research has focused on the role of these proteins in rheumatoid arthritis, inflammatory bowel disease, kidney disease, chronic liver injury, systemic lupus erythematosus, neurological diseases, and asthma, just to mention a few. There is evidence that brown adipose tissue has its own set of secreted hormones, so-called “brown adipokines”. These factors exert autocrine and endocrine functions beyond their role in thermogenic function. Adipokine receptors are less well characterized, and analysis of their tissue distribution and biological activities awaits further investigation. Development of adipokine receptor agonists and antagonists opens up new avenues of drugs and may finally lead to new therapeutic targets and the appreciation of more adipokines in clinical practice.
Prof. Dr. Christa Büchler
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- white adipose tissue
- brown adipose tissue
- metabolic diseases
- adipokine receptor